CMS Issues PAMA Final Rule That Aims to Cut Medicare’s Clinical Laboratory Test Price Schedule Sharply Beginning in 2018

Analysis shows new rule requires data gathering effort that favors larger medical laboratories and thus threatens community labs that serve smaller towns and rural areas When The Centers for Medicare and Medicaid Services (CMS) issued their Final Rule for lab test market price reporting under the Protecting Access to Medicare Act of 2014 (PAMA) last month, it put the clinical laboratory industry on a path that will have significant financial consequences for all labs, whether large or small....

Feds to Destroy Bid Documents for Medicare’s Clinical Laboratory Competitive Bidding Demonstration Project in San Diego

Following an agreement by federal attorneys to destroy the lab bidder’s documents, a federal judge dismisses the case Last month in a San Diego courtroom, federal attorneys agreed to destroy the clinical pathology laboratory bid documents that had been submitted as part of the poorly-conceived Medicare Part B Laboratory Competitive Bidding Demonstration Project that the Centers for Medicare and Medicaid (CMS) attempted to implement in 2008. An agreement to destroy the bid documents was...
;